Full-Time

Associate Director

New Device Technology Programs

Posted on 11/30/2024

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

Senior

Cambridge, MA, USA

US and Puerto Rico Residents Only.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • BS degree in engineering, life science or related discipline and 10+ years related work experience, or MS/PhD with 5+ years related work experience. MBA a plus
  • Experience working with research and clinical development teams, solid understanding of related issues and challenges
  • Experience in third party management (of manufacturers and vendors) is preferred
  • Expertise around regulatory requirements for parenteral combination products is preferred (21 CFR parts 4 & 820, ISO 13485, 14971 & IEC 62366)
  • Strong knowledge of the US/EU external device-mediated drug delivery technology innovation eco-system
  • Solid experience of technology development through external partnership with third parties
  • Strong leadership, communication, and presentation skills
  • Capable of capturing unmet needs and translating them into product requirements
  • International business experience leading multicultural and / or multinational team(s)
  • Play to win mindset
  • Extensive experience with successfully influencing and rapid decision making in matrix and / or governance driven environments
  • Attention to details with meticulous planning
Responsibilities
  • Lead and facilitate device technology innovation and development based on clinical and patient needs, commercial and operational requirements and industry trends, create impactful solutions to expand Sanofi device IP portfolio and strength
  • Work with new device technology research team to evaluate new device technology and product solutions
  • Conduct required studies and impact assessment by working with internal and external partners and stakeholders to establish technical and commercial feasibility
  • Advance the novel technology and product concepts to be clinical ready and create full development roadmap
  • Embedded into cross-functional program teams serving as the single point of contact of GDPU function for innovation programs
  • Synthesize program needs and leverage learnings from different programs, identify platform opportunity when possible
  • Interface with internal and external device development partners to align resource and priorities to transition and support new device development programs
  • Align with key stakeholders on the selected device solution to meet clinical program needs
  • Generate the integrated development plan and resource need
  • Manage all device related development activities to ensure on-time, on-budget execution
  • Provide support and leadership in due diligence efforts involving novel device technologies

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi's products include prescription medicines, over-the-counter items, and vaccines, which are distributed to patients, healthcare professionals, and governments. What sets Sanofi apart from its competitors is its strong emphasis on scientific innovation and strategic partnerships, allowing it to maintain a diverse pipeline of new products. The company's goal is to enhance health outcomes and improve the quality of life for people globally by delivering effective and safe healthcare solutions.

Company Stage

IPO

Total Funding

$2B

Headquarters

Paris, France

Founded

1973

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Sanofi's strong financial performance, as evidenced by its raised 2024 outlook, indicates robust growth and stability.
  • The company's strategic investments in innovative biotech firms, such as Ventyx Biosciences, enhance its pipeline and potential for breakthrough therapies.
  • Sanofi's Dupixent receiving a positive recommendation for expanded use in children demonstrates its leadership in addressing unmet medical needs.

What critics are saying

  • The highly competitive pharmaceutical market requires Sanofi to continuously innovate to maintain its market position.
  • Regulatory challenges in different regions could delay product approvals and impact revenue streams.

What makes Sanofi unique

  • Sanofi's extensive R&D efforts and strategic partnerships, such as with Orano Med for radioligand therapies, set it apart in the competitive pharmaceutical landscape.
  • The company's global reach and focus on patient-centric solutions allow it to effectively navigate diverse regulatory environments and deliver innovative treatments worldwide.
  • Sanofi's investment in sustainable initiatives, like SureChill's 'Cooling as a Service' model, highlights its commitment to addressing healthcare challenges in emerging markets.

Help us improve and share your feedback! Did you find this helpful?